---
ver: rpa2
title: Multimodal Clinical Trial Outcome Prediction with Large Language Models
arxiv_id: '2402.06512'
source_url: https://arxiv.org/abs/2402.06512
tags:
- trial
- lifted
- phase
- modalities
- clinical
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This paper introduces LIFTED, a multimodal mixture-of-experts approach
  for clinical trial outcome prediction that addresses the challenge of extracting
  representations from diverse data modalities using a unified transformer-based encoder.
  LIFTED transforms different modality data into natural language descriptions, employs
  a sparse Mixture-of-Experts (SMoE) framework to identify similar information patterns
  across modalities, and uses a consistency loss with representation augmentation
  to enhance robustness to data noise.
---

# Multimodal Clinical Trial Outcome Prediction with Large Language Models

## Quick Facts
- arXiv ID: 2402.06512
- Source URL: https://arxiv.org/abs/2402.06512
- Reference count: 24
- Primary result: LIFTED achieves 3.9-9.3% improvement in PR-AUC, 2.4-6.1% in F1-score, and 1.7-4.5% in ROC-AUC over baselines across all three clinical trial phases

## Executive Summary
This paper introduces LIFTED, a novel multimodal mixture-of-experts approach for predicting clinical trial outcomes by addressing the challenge of extracting representations from diverse data modalities. The method transforms different clinical data types into natural language descriptions, uses a sparse Mixture-of-Experts framework to identify similar information patterns across modalities, and employs consistency loss with representation augmentation to enhance robustness to data noise. LIFTED integrates multimodal information using a Mixture-of-Experts module to dynamically weigh different modalities for prediction. Experiments on HINT and CTOD datasets demonstrate significant performance improvements across all three clinical trial phases compared to baseline methods.

## Method Summary
LIFTED addresses the challenge of multimodal clinical trial outcome prediction through a transformer-based encoder that processes diverse clinical data types by converting them into natural language descriptions. The method employs a sparse Mixture-of-Experts (SMoE) framework to identify similar information patterns across different modalities, allowing the model to recognize shared features between diverse data types. To enhance robustness to data noise, LIFTED incorporates a consistency loss with representation augmentation techniques. The integration of multimodal information is achieved through a dedicated Mixture-of-Experts module that dynamically weighs the importance of different modalities for final prediction, allowing the model to adaptively focus on the most relevant information sources for each clinical trial outcome prediction task.

## Key Results
- LIFTED achieves 3.9-9.3% improvement in PR-AUC over baselines across all three clinical trial phases
- Model shows 2.4-6.1% improvement in F1-score compared to existing methods
- LIFTED demonstrates 1.7-4.5% enhancement in ROC-AUC on HINT and CTOD datasets

## Why This Works (Mechanism)
The paper's mechanism relies on transforming heterogeneous clinical data into a unified natural language representation space, which enables the transformer encoder to process all modalities through a common architecture. The sparse Mixture-of-Experts framework identifies cross-modal patterns by learning to route similar information across different data types, effectively creating a shared semantic space where diverse clinical features can be compared and combined. The consistency loss and representation augmentation techniques improve robustness by forcing the model to maintain stable predictions despite data perturbations, which is particularly valuable in clinical settings where data quality and completeness can vary significantly across trials and patient records.

## Foundational Learning
- **Natural Language Transformation**: Converting clinical data modalities into text descriptions allows unified processing through transformer architectures - needed because traditional multimodal models struggle with heterogeneous clinical data types, quick check: verify that converted text preserves all clinically relevant information
- **Sparse Mixture-of-Experts**: SMoE enables efficient routing of similar patterns across modalities by activating only relevant expert networks - needed to avoid computational complexity of full multimodal fusion, quick check: examine expert activation patterns for clinical interpretability
- **Consistency Loss**: Regularization technique that maintains prediction stability under data perturbations - needed because clinical data often contains noise and missing values, quick check: test model performance on intentionally corrupted clinical datasets
- **Representation Augmentation**: Data augmentation applied to learned representations rather than raw input - needed to enhance model robustness to noise in clinical trial data, quick check: measure performance degradation with increasing noise levels
- **Dynamic Modality Weighting**: Mixture-of-Experts module that assigns importance weights to different modalities - needed because not all data types contribute equally to outcome prediction, quick check: analyze modality weight distributions across different trial phases
- **Transformer-based Encoder**: Unified architecture for processing transformed natural language clinical descriptions - needed to leverage pre-trained language model capabilities for clinical data, quick check: compare performance with different pre-training strategies

## Architecture Onboarding

Component Map: Clinical Data -> Text Transformation -> Transformer Encoder -> SMoE Routing -> Modality Integration -> Consistency Loss -> Final Prediction

Critical Path: The most critical components are the text transformation layer (which determines information fidelity) and the SMoE routing mechanism (which enables cross-modal pattern recognition). The consistency loss and representation augmentation work together to ensure robustness, while the dynamic modality weighting allows adaptive integration of the most relevant information sources.

Design Tradeoffs: The primary tradeoff involves information loss during text transformation versus the benefits of unified processing. Converting complex clinical data (imaging, lab results, demographics) into natural language may discard subtle patterns that specialized modality-specific encoders could capture. The SMoE approach trades some precision for computational efficiency and cross-modal generalization.

Failure Signatures: The model may fail when clinical data contains information that cannot be adequately expressed in natural language, such as subtle imaging patterns or complex temporal relationships. It may also struggle with rare clinical scenarios where modality-specific expertise is crucial, or when the consistency loss over-regularizes and suppresses legitimate variability in clinical presentations.

First Experiments:
1. Ablation study removing text transformation to test information loss impact on prediction accuracy
2. Comparison with modality-specific expert models to quantify SMoE generalization benefits
3. Stress test with increasing levels of data noise to measure consistency loss effectiveness

## Open Questions the Paper Calls Out
None

## Limitations
- Information loss during text transformation of clinical data modalities may discard clinically relevant patterns
- SMoE framework may struggle with domain-specific clinical scenarios where modality-specific information is crucial
- Consistency loss assumptions about noise distributions may not hold across all trial types

## Confidence
- High Confidence: Performance improvements on HINT and CTOD datasets are well-supported by reported metrics
- Medium Confidence: Integration of diverse clinical data modalities through unified framework is plausible but lacks component necessity ablation
- Medium Confidence: Claims about identifying cross-modal patterns need qualitative clinical validation

## Next Checks
1. Conduct blinded clinical expert review to assess whether model predictions and representations align with medical reasoning
2. Perform systematic ablation experiments measuring false positive/negative rates for critical clinical outcomes
3. Test LIFTED on external clinical trial datasets from different therapeutic areas to assess generalizability